BeautyHealth 2023 Skintuition Report: The Skin Health Trends and Data Shaping the Year
December 12 2023 - 8:00AM
Business Wire
The Beauty Health Company (NASDAQ: SKIN), home to flagship brand
Hydrafacial, today revealed its inaugural Skintuition Report, a
compilation of insights, trends and predictions based on clinical
studies, data and performance from the Company’s pioneering brands,
and input of its global network of professional skin health
providers.
This collective intelligence and proprietary data put
BeautyHealth in a unique position to reflect on the trends that
shaped 2023 and those that it believes will emerge in 2024.
“We are thrilled to unveil our first-ever Skintuition Report and
share insights culled from our connected platform and global
community of skin health providers. This year’s data reveals an
appetite for retro ingredients with novel delivery methods and a
growing interest in body—especially booty—skincare treatments,”
says BeautyHealth Chief Marketing and Communications Officer Amy
Juaristi. “What’s more, consumers continue to show they are
committed to investing to achieve flawless skin, often combining
Hydrafacial with other aesthetic treatments—a trend we see as the
ultimate quiet luxury power play.”
The Skintuition Report shows that Peptides, Retinol and Vitamin
C were the tried-and-true ingredients favored by providers in 2023
when it came to selecting boosters to personalize every Hydrafacial
treatment to address clients’ skincare needs. And, Hydrafacial
treatments moved beyond the face with back and booty treatments
increasing +133% compared to last year.
In addition to consumer and provider behavior data, the 2023
BeautyHealth Skintuition Report catalogues long-standing and more
recent peer-reviewed clinical studies, which analyze the efficacy
of the Hydrafacial treatment. Among the findings, study
investigators found Hydrafacial treatments:
- significantly improve hydration, pore size, hyperpigmentation,
dullness, fine lines, and texture1,2
- work at deeper levels in the skin to help thicken, plumpen and
protect the skin from free radicals and pollution1,2
- significantly improve acne in the majority of subjects3
“Hydrafacial has decades of proven efficacy, shown in our
catalogue of clinical studies and in the everyday use by clinicians
worldwide for glowing results,” says BeautyHealth Medical Affairs
Leader Juan Valesquez, Ph.D. “These findings further validate what
many Hydrafacial providers have known all along: aesthetic
treatments can come and go, but Hydrafacial is here to stay.”
As for 2024 predictions, the Skintuition Report lays out five
themes poised to dominate the skin health conversation:
- Medicalization of Beauty: Consumers seeking the biggest
bang for their beauty dollar and efficacy above all will invest in
proven treatments, backed by clinical studies.
- Rise of the New Influencer: Consumers will increasingly
turn to skin health professionals—MDs and estheticians—to help
shape their beauty routines.
- Flawless Skin, The Ultimate Quiet Luxury: Impeccable
skin will be a subtle statement—or a very loud one for those in the
know—signaling an investment of money, time and knowledge in
treatments, tweakments and products.
- Retro Ingredients, New Delivery Methods: Providers are
reaching for tried-and-true ingredients like peptides, finding
novelty and efficacy in new formulas or with device-supported
applications.
- Personalization Powered by Data: Data will play a
starring role in how products and treatments will be enhanced and
personalized to consumers’ needs.
Data insights in the Skintuition Report are generated from
BeautyHealth sales data, Hydrafacial Syndeo device data, published
clinical studies, provider testimonials, and third-party
measurement tools.
Download the full 2023 BeautyHealth Skintuition Report here.
- Bruce M. Freedman (2009) Topical antioxidant application
enhances the effects of facial microdermabrasion, Journal of
Dermatological Treatment.
- Bruce M. Freedman (2008) Hydradermabrasion: an innovative
modality for nonablative facial rejuvenation, Journal of Cosmetic
Dermatology.
- Ryan Storgard, MS*; Jana Mauricio-Lee, BS*; Tess Mauricio, MD;
Martin Zaiac, MD; and Jwala Karnik, MD (2022) Efficacy and
Tolerability of HydraFacial Clarifying Treatment Series in the
Treatment of Active Acne Vulgaris, Journal of Clinical and
Aesthetic Dermatology.
About The Beauty Health Company
The Beauty Health Company (NASDAQ: SKIN) is a global
category-creating company delivering millions of skin health
experiences every year that help consumers reinvent their
relationship with their skin, bodies, and self-confidence. Our
brands are pioneers: Hydrafacial™ in hydradermabrasion, SkinStylus™
in microneedling, and Keravive™ in scalp health. Together, with our
powerful community of estheticians, partners, and consumers, we are
personalizing skin health for all ages, genders, skin tones, and
skin types in more than 90 countries. We are committed to being
ever more mindful in how we conduct our business to positively
impact our communities and the planet. Find a local provider at
https://hydrafacial.com/find-a-provider/ and learn more at
beautyhealth.com or LinkedIn.
Forward-Looking Statements
Certain statements made in this release are “forward looking
statements” within the meaning of the “safe harbor” provisions of
the United States Private Securities Litigation Reform Act of 1995.
When used in this press release, the words “estimates,”
“projected,” “expects,” “anticipates,” “forecasts,” “plans,”
“intends,” “believes,” “seeks,” “may,” “will,” “should,” “future,”
“propose” and variations of these words or similar expressions (or
the negative versions of such words or expressions) are intended to
identify forward-looking statements.
These forward-looking statements are not guarantees of future
performance, conditions, or results, and involve a number of known
and unknown risks, uncertainties, assumptions, and other important
factors, many of which are outside The Beauty Health Company’s
control, that could cause actual results or outcomes to differ
materially from those discussed in the forward-looking
statements.
Important factors, among others, that may affect actual results
or outcomes include The Beauty Health Company’s ability to execute
its business plan; the ability to accurately predict consumer
trends and needs; the methods in which estheticians and other
providers work; the ability to attract, convert, and keep consumers
to the Hydrafacial brand; potential litigation involving The Beauty
Health Company; changes in applicable laws or regulations; and the
possibility that The Beauty Health Company may be adversely
affected by other economic, business, and/or competitive factors.
The Beauty Health Company does not undertake any obligation to
update or revise any forward-looking statements, whether because of
new information, future events, or otherwise, except as required by
law.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231212612115/en/
Hydrafacial Media: Marina Maher Communications |
HydraFacial@hellommc.com
Beauth Health (NASDAQ:SKIN)
Historical Stock Chart
From Oct 2024 to Oct 2024
Beauth Health (NASDAQ:SKIN)
Historical Stock Chart
From Oct 2023 to Oct 2024